Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer

NCT06980532 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
42
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Liu Huang